Adeshwar Meditex board to meet on May 21 for FY26 results

1 min read     Updated on 14 May 2026, 11:06 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Adeshwar Meditex Limited will hold a board meeting on May 21, 2026, to approve audited financial results for the year and half-year ended March 31, 2026. The board will also note the internal audit report and the resignation of an independent director. The trading window is closed from April 1 until 48 hours post-results announcement.

powered bylight_fuzz_icon
40325765

*this image is generated using AI for illustrative purposes only.

adeshwar meditex has announced that its board of directors will meet on Thursday, May 21, 2026, through video conferencing. The primary agenda for the meeting is to consider and approve the standalone audited financial results for the half year and financial year ended March 31, 2026.

Agenda Details

In addition to the financial results, the board will take note of the internal audit report for the financial year ended March 31, 2026. The directors will also acknowledge the resignation of Mr. Arun Koli from the post of Independent Director of the company. Any other matter with the permission of the Chair may also be discussed during the meeting.

Trading Window Closure

Pursuant to SEBI regulations, the trading window for the company's securities has been closed since April 1, 2026. This closure will remain in effect until 48 hours after the announcement of the financial results on May 21, 2026. During this period, designated persons, including promoters, directors, connected persons, insiders, and their immediate relatives, are prohibited from trading in the company's shares or securities.

Compliance

The intimation regarding the board meeting has been submitted to BSE Limited in compliance with Regulation 29 and/or 33 of the SEBI (LODR) Regulations, 2015. The company has scrip code 543309 and scrip ID ADESHWAR on the exchange.

How might Adeshwar Meditex's audited financial results for FY2026 compare to the previous year, and what revenue or profitability trends could emerge from the medtech sector?

Who is likely to succeed Mr. Arun Koli as Independent Director, and how could the change in board composition affect corporate governance and investor confidence?

Could the resignation of an Independent Director signal any underlying strategic shifts or challenges within Adeshwar Meditex's leadership structure?

Adeshwar Meditex Reappoints M/s. Basude Makote & Saini as Internal Auditors for FY 2025-26 to 2027-28

1 min read     Updated on 14 May 2026, 10:00 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Adeshwar Meditex Limited's Board of Directors approved the reappointment of M/s. Basude Makote & Saini, Chartered Accountants (FRN No. 124381W), as Internal Auditors for FY 2025-26 to 2027-28 at its meeting on May 14, 2026. The firm has been serving as Internal Auditor since August 26, 2023, and the reappointment was made under Section 138 of the Companies Act, 2013. The disclosure was filed with BSE Limited under Regulation 30 of the SEBI (LODR) Regulations, 2015. The board meeting was held from 4:00 PM to 4:30 PM (IST) and was authorized by Whole-time Director Krishnojirao Nagaraja Rao.

powered bylight_fuzz_icon
40321798

*this image is generated using AI for illustrative purposes only.

Adeshwar Meditex Limited announced the reappointment of M/s. Basude Makote & Saini, Chartered Accountants, as its Internal Auditors for the financial years 2025-26 to 2027-28. The decision was taken at a Board of Directors meeting held on May 14, 2026, commencing at 4:00 PM (IST) and concluding at 4:30 PM (IST). The reappointment was made pursuant to Section 138 of the Companies Act, 2013, and the disclosure was submitted to BSE Limited under Regulation 30 of the SEBI (LODR) Regulations, 2015.

Reappointment Details

The following key details of the reappointment were disclosed by the company:

Parameter: Details
Name of Internal Auditors: M/s. Basude Makote & Saini
FRN No.: 124381W
Membership No.: 183122
Date of Appointment: May 14, 2026
Tenure: FY 2025-26 to FY 2027-28
Internal Auditor Since: August 26, 2023
Statutory Basis: Section 138 of the Companies Act, 2013

Profile of M/s. Basude Makote & Saini

M/s. Basude Makote & Saini is a well-established Chartered Accountant firm with extensive experience working with corporate entities, LLPs, partnership firms, banks, and co-operatives. The firm offers a broad range of professional services, as highlighted below:

  • Statutory Audit and Internal Audit
  • Stock Audit and Forensic Audit
  • Project Financing
  • Direct and Indirect Tax Consultancy
  • Due Diligence and Legal Services
  • Preparation and Finalization of Balance Sheets for companies, firms, educational institutions, and other organizations
  • Reconciliation of Accounts
  • Extensive litigation before appeal

The firm is also engaged in rendering legal and due diligence services to various industries and corporates across the country.

Board Authorization

The reappointment was authorized by Krishnojirao Nagaraja Rao, Whole-time Director (DIN: 07684308), on behalf of Adeshwar Meditex Limited. The company noted that there is no disclosure of relationships between directors applicable in this case, as the appointment pertains to an auditing firm and not a director. The outcome of the board meeting was communicated to BSE Limited for record purposes in compliance with applicable regulatory requirements.

How might the three-year tenure of M/s. Basude Makote & Saini as internal auditors impact Adeshwar Meditex's financial governance and compliance standards through FY 2027-28?

Could the continuity of the same internal audit firm since 2023 raise concerns about auditor independence, and how might regulators or investors respond to this extended relationship?

What strategic financial initiatives or expansions is Adeshwar Meditex planning that may necessitate the broader forensic audit and due diligence capabilities offered by the reappointed firm?

More News on Adeshwar Meditex